With almost $50 billion spent on worldwide pharmaceutical R&D in 1999 and continued huge increases in R&D spending, one would think the rate of drugs making it to market is increasing. Yet while new-chemical-entity development time has decreased from 13.5 to 11 years, it’s still too long. Further, despite the novel information generated by the genomics craze, results have lagged.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.